| Authors: |
van Barele M; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Centre Rotterdam, Rotterdam, The Netherlands., Buis CCM; Department of Gynecologic Oncology, Erasmus MC Cancer Institute, University Medical Centre Rotterdam, Rotterdam, The Netherlands.; Present address: Department of Gynecology, Nij Smellinghe Hospital, Drachten, The Netherlands., Brood-van Zanten MMA; Department of Gynecology, Amsterdam University Medical Centre and Antoni van Leeuwenhoek, Amsterdam, The Netherlands., van Doorn HLC; Department of Gynecologic Oncology, Erasmus MC Cancer Institute, University Medical Centre Rotterdam, Rotterdam, The Netherlands., Gaarenstroom KN; Department of Gynecology and Obstetrics, Leiden University Medical Centre, Leiden, The Netherlands., Heemskerk-Gerritsen BAM; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Centre Rotterdam, Rotterdam, The Netherlands., Hooning MJ; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Centre Rotterdam, Rotterdam, The Netherlands., de Hullu J; Department of Gynecologic Oncology, Radboud University Medical Centre, Nijmegen, The Netherlands., Mourits MJ; Department of Gynecologic Oncology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands., Burger CW; Department of Gynecologic Oncology, Erasmus MC Cancer Institute, University Medical Centre Rotterdam, Rotterdam, The Netherlands. |
